Daniel Gibson - Telesis Bio Chief Officer
| TBIODelisted Stock | USD 2.98 0.02 0.67% |
Executive
Daniel Gibson is Chief Officer of Telesis Bio
| Age | 47 |
| Phone | 858 228 4115 |
| Web | https://telesisbio.com |
Daniel Gibson Latest Insider Activity
Tracking and analyzing the buying and selling activities of Daniel Gibson against Telesis Bio pink sheet is an integral part of due diligence when investing in Telesis Bio. Daniel Gibson insider activity provides valuable insight into whether Telesis Bio is net buyers or sellers over its current business cycle. Note, Telesis Bio insiders must abide by specific rules, including filing SEC forms every time they buy or sell Telesis Bio'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Daniel Gibson over six months ago Acquisition by Daniel Gibson of 51500 shares of Telesis Bio at 1.66 subject to Rule 16b-3 |
Telesis Bio Management Efficiency
The company has return on total asset (ROA) of (0.2652) % which means that it has lost $0.2652 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.4784) %, meaning that it created substantial loss on money invested by shareholders. Telesis Bio's management efficiency ratios could be used to measure how well Telesis Bio manages its routine affairs as well as how well it operates its assets and liabilities.Telesis Bio currently holds 34.38 M in liabilities with Debt to Equity (D/E) ratio of 0.16, which may suggest the company is not taking enough advantage from borrowing. Telesis Bio has a current ratio of 5.81, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Telesis Bio until it has trouble settling it off, either with new capital or with free cash flow. So, Telesis Bio's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Telesis Bio sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Telesis to invest in growth at high rates of return. When we think about Telesis Bio's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Robert Harris | Lifevantage | 55 | |
| Alissa Neufeld | Lifevantage | 44 | |
| Eric Marchant | Lifevantage | N/A | |
| Edric Funk | Toro Co | N/A | |
| Mark Dely | Vera Bradley | 48 | |
| Jason Baab | Toro Co | 50 | |
| Jeffrey Fleming | Eastern Co | N/A | |
| Georg Bettin | Acme United | N/A | |
| Alison Hiatt | Vera Bradley | 53 | |
| Branden Happel | Toro Co | N/A | |
| Pamela Sours | Vera Bradley | N/A | |
| Theresa Dews | Eastern Co | N/A | |
| Carl CPA | Lifevantage | 51 | |
| Ryan Schroeder | Eastern Co | N/A | |
| Philip Campbell | AMCON Distributing | 62 | |
| Kevin Smith | Toro Co | N/A | |
| Eiichi Shiokawa | Lifevantage | N/A | |
| Margeaux King | Toro Co | 46 | |
| Beatrice Cabe | Vera Bradley | 45 | |
| Calli Mott | Lifevantage | N/A | |
| Julie Kerekes | Toro Co | N/A | |
Management Performance
| Return On Equity | -1.48 | ||||
| Return On Asset | -0.27 |
Telesis Bio Leadership Team
Elected by the shareholders, the Telesis Bio's board of directors comprises two types of representatives: Telesis Bio inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Telesis. The board's role is to monitor Telesis Bio's management team and ensure that shareholders' interests are well served. Telesis Bio's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Telesis Bio's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Decky MBA, Senior Development | ||
| Laura MBA, Vice Culture | ||
| Richard Lepke, Director Relations | ||
| Jen Carroll, Vice Relations | ||
| Laurence Warden, Senior Instrumentation | ||
| William Kullback, Chief Officer | ||
| Dr MBA, Founder Director | ||
| Daniel Gibson, Chief Officer | ||
| Robert Cutler, Chief Officer | ||
| Eric Esser, CEO, President |
Telesis Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Telesis Bio a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.48 | ||||
| Return On Asset | -0.27 | ||||
| Profit Margin | (2.53) % | ||||
| Operating Margin | (6.76) % | ||||
| Current Valuation | 61.1 M | ||||
| Shares Outstanding | 1.77 M | ||||
| Shares Owned By Insiders | 37.90 % | ||||
| Shares Owned By Institutions | 32.97 % | ||||
| Number Of Shares Shorted | 29.7 K | ||||
| Price To Earning | 71.32 X |
Pair Trading with Telesis Bio
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Telesis Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Telesis Bio will appreciate offsetting losses from the drop in the long position's value.Moving against Telesis Pink Sheet
| 0.63 | SYK | Stryker | PairCorr |
| 0.62 | NXL | Nexalin Technology | PairCorr |
| 0.61 | PEN | Penumbra | PairCorr |
| 0.6 | VREX | Varex Imaging Corp | PairCorr |
| 0.6 | FNA | Paragon 28 | PairCorr |
The ability to find closely correlated positions to Telesis Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Telesis Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Telesis Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Telesis Bio to buy it.
The correlation of Telesis Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Telesis Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Telesis Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Telesis Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Consideration for investing in Telesis Pink Sheet
If you are still planning to invest in Telesis Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Telesis Bio's history and understand the potential risks before investing.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |